AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38
Remission of metastatic cervical adenocarcinoma with weekly paclitaxel
Authors: Ota, S Sugiyama, T Ushijima, K Fujiyoshi, K Komai, K Hirai, N Nishida, T Kamura, T
Citation: S. Ota et al., Remission of metastatic cervical adenocarcinoma with weekly paclitaxel, INT J GYN C, 11(2), 2001, pp. 167-168
Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism, involving a Cullin-containing complex
Authors: Querido, E Blanchette, P Yan, Q Kamura, T Morrison, M Boivin, D Kaelin, WG Conaway, RC Conaway, JW Branton, PE
Citation: E. Querido et al., Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism, involving a Cullin-containing complex, GENE DEV, 15(23), 2001, pp. 3104-3117
Weekly 1 hour paclitaxel infusion in patients with recurrent gynecologicaltumors: a pilot study
Authors: Ota, S Sugiyama, T Komai, K Hirai, N Kumagai, S Ushijima, K Nishida, T Kamura, T
Citation: S. Ota et al., Weekly 1 hour paclitaxel infusion in patients with recurrent gynecologicaltumors: a pilot study, JPN J CLIN, 31(8), 2001, pp. 395-398
Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome
Authors: Kaku, T Yoshikawa, H Tsuda, H Sakamoto, A Fukunaga, M Kuwabara, Y Hataeg, M Kodama, S Kuzuya, K Sato, S Nishimura, T Hiura, M Nakano, H Iwasaka, T Miyazaki, K Kamura, T
Citation: T. Kaku et al., Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome, CANCER LETT, 167(1), 2001, pp. 39-48
Prognostic factors of stage IV epithelial ovarian cancer: A multicenter retrospective study
Authors: Akahira, JI Yoshikawa, H Shimizu, Y Tsunematsu, R Hirakawa, T Kuramoto, H Shiromizu, K Kuzuya, K Kamura, T Kikuchi, Y Kodama, S Yamamoto, K Sato, S
Citation: Ji. Akahira et al., Prognostic factors of stage IV epithelial ovarian cancer: A multicenter retrospective study, GYNECOL ONC, 81(3), 2001, pp. 398-403
Impact on survival following successful neoadjuvant chemotherapy and radical surgery for Stage IIb bulky and Stage IIIb cervical cancer
Authors: Sugiyama, T Hasuo, Y Nishida, T Kamura, T
Citation: T. Sugiyama et al., Impact on survival following successful neoadjuvant chemotherapy and radical surgery for Stage IIb bulky and Stage IIIb cervical cancer, GYNECOL ONC, 81(2), 2001, pp. 330-331
MUF1, a novel Elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase
Authors: Kamura, T Burian, D Yan, Q Schmidt, SL Lane, WS Querido, E Branton, PE Shilatifard, A Conaway, RC Conaway, JW
Citation: T. Kamura et al., MUF1, a novel Elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase, J BIOL CHEM, 276(32), 2001, pp. 29748-29753
Cloning and characterization of ELL-associated proteins EAP45 and EAP20 - A role for yeast EAP-like proteins in regulation of gene expression by glucose
Authors: Kamura, T Burian, D Khalili, H Schmidt, SL Sato, S Liu, WJ Conrad, MN Conaway, RC Conaway, JW Shilatifard, A
Citation: T. Kamura et al., Cloning and characterization of ELL-associated proteins EAP45 and EAP20 - A role for yeast EAP-like proteins in regulation of gene expression by glucose, J BIOL CHEM, 276(19), 2001, pp. 16528-16533
Relationship between age, histological type, and size of ovarian tumors
Authors: Okugawa, K Hirakawa, T Fukushima, K Kamura, T Amada, S Nakano, H
Citation: K. Okugawa et al., Relationship between age, histological type, and size of ovarian tumors, INT J GYN O, 74(1), 2001, pp. 45-50
Synthesis and molecular structure of the amido-bridged dinuclear rhodium complex [CpRh{mu(2)-(NH)(2)C10H6-2,3}(mu(2)-Cl)RhCp*][PF6] (Cp* = eta(5)-C5Me5)
Authors: Matsuzaka, H Kamura, T Ariga, K Okubo, T Ishii, T Yamashita, M Kondo, M Kitagawa, S
Citation: H. Matsuzaka et al., Synthesis and molecular structure of the amido-bridged dinuclear rhodium complex [CpRh{mu(2)-(NH)(2)C10H6-2,3}(mu(2)-Cl)RhCp*][PF6] (Cp* = eta(5)-C5Me5), MOLEC CRYST, 342, 2000, pp. 1-6
Expression of tumor-rejection antigens in gynecologic cancers
Authors: Tanaka, S Tsuda, N Kawano, K Sakamoto, M Nishida, T Hashimoto, T Shichijo, S Kamura, T Itoh, K
Citation: S. Tanaka et al., Expression of tumor-rejection antigens in gynecologic cancers, JPN J CANC, 91(11), 2000, pp. 1177-1184
DNA polymorphism analysis of a pure non-gestational choriocarcinoma of theovary: case report
Authors: Shigematsu, T Kamura, T Arima, T Wake, N Nakano, H
Citation: T. Shigematsu et al., DNA polymorphism analysis of a pure non-gestational choriocarcinoma of theovary: case report, EUR J GYN O, 21(2), 2000, pp. 153-154
Successful treatment of two patients with recurrent endometrial cancer by weekly paclitaxel
Authors: Ota, S Sugiyama, T Ushijima, K Komai, K Fujiyoshi, K Hirai, N Nishida, T Kamura, T
Citation: S. Ota et al., Successful treatment of two patients with recurrent endometrial cancer by weekly paclitaxel, CANCER LETT, 160(1), 2000, pp. 9-12
Preparation, structure, and reactivities of amido-bridged dinuclear rhodium(III) and rhodium(II) complexes
Authors: Matsuzaka, H Kamura, T Ariga, K Watanabe, Y Okubo, T Ishii, T Yamashita, M Kondo, M Kitagawa, S
Citation: H. Matsuzaka et al., Preparation, structure, and reactivities of amido-bridged dinuclear rhodium(III) and rhodium(II) complexes, ORGANOMETAL, 19(3), 2000, pp. 216-218
Ovarian endometriosis associated with ovarian carcinoma: A clinicopathological and immunohistochemical study
Authors: Ogawa, S Kaku, T Amada, S Kobayashi, H Hirakawa, T Ariyoshi, K Kamura, T Nakano, H
Citation: S. Ogawa et al., Ovarian endometriosis associated with ovarian carcinoma: A clinicopathological and immunohistochemical study, GYNECOL ONC, 77(2), 2000, pp. 298-304
Activation of HIF1 alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex
Authors: Kamura, T Sato, S Iwai, K Czyzyk-Krzeska, M Conaway, RC Conaway, JW
Citation: T. Kamura et al., Activation of HIF1 alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex, P NAS US, 97(19), 2000, pp. 10430-10435
Identification of a new endoplasmic reticulum-resident protein recognized by HLA-A24-restricted tumor-infiltrating lymphocytes of lung cancer
Authors: Kawano, K Gomi, S Tanaka, K Tsuda, N Kamura, T Itoh, K Yamada, A
Citation: K. Kawano et al., Identification of a new endoplasmic reticulum-resident protein recognized by HLA-A24-restricted tumor-infiltrating lymphocytes of lung cancer, CANCER RES, 60(13), 2000, pp. 3550-3558
Clinical characteristics of clear cell carcinoma of the ovary - A distincthistologic type with poor prognosis and resistance to platinum-based chemotherapy
Authors: Sugiyama, T Kamura, T Kigawa, J Terakawa, N Kikuchi, Y Kita, T Suzuki, W Sato, I Taguchi, K
Citation: T. Sugiyama et al., Clinical characteristics of clear cell carcinoma of the ovary - A distincthistologic type with poor prognosis and resistance to platinum-based chemotherapy, CANCER, 88(11), 2000, pp. 2584-2589
The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix
Authors: Kaku, T Sonoda, K Kamura, T Hirakawa, T Sakai, K Amada, S Ogawa, S Kobayashi, H Nakashima, M Watanabe, T Nakano, H
Citation: T. Kaku et al., The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix, CLIN CANC R, 5(6), 1999, pp. 1449-1453
Comparison of p53 and CD44 variant 6 expression between paired primary andrecurrent ovarian cancer: An immunohistochemical analysis
Authors: Kamura, T Sakai, K Kaku, T Kobayashi, H Mitsumoto, M Tsuneyoshi, M Nakano, H
Citation: T. Kamura et al., Comparison of p53 and CD44 variant 6 expression between paired primary andrecurrent ovarian cancer: An immunohistochemical analysis, ONCOL REP, 6(1), 1999, pp. 97-101
The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase activates Rub1 modification of cullins Cdc53 and Cul2
Authors: Kamura, T Conrad, MN Yan, Q Conaway, RC Conaway, JW
Citation: T. Kamura et al., The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase activates Rub1 modification of cullins Cdc53 and Cul2, GENE DEV, 13(22), 1999, pp. 2928-2933
Prognostic significance of epithelial-stromal vascular cuffing and microvessel density in squamous cell carcinoma of the uterine cervix
Authors: Hirakawa, T Kamura, T Kaku, T Amada, S Ariyoshi, K Kinukawa, N Nakano, H
Citation: T. Hirakawa et al., Prognostic significance of epithelial-stromal vascular cuffing and microvessel density in squamous cell carcinoma of the uterine cervix, GYNECOL ONC, 74(3), 1999, pp. 369-374
Comparison of p53, Ki-67, and CD44v6 expression between primary and matched metastatic lesions in ovarian cancer
Authors: Sakai, K Kaku, T Kamura, T Kinukawa, N Amada, S Shigematsu, T Hirakawa, T Kobayashi, H Ariyoshi, K Nakano, H
Citation: K. Sakai et al., Comparison of p53, Ki-67, and CD44v6 expression between primary and matched metastatic lesions in ovarian cancer, GYNECOL ONC, 72(3), 1999, pp. 360-366
Predicting pelvic lymph node metastasis in endometrial carcinoma
Authors: Kamura, T Yahata, H Shigematsu, T Ogawa, S Amada, S Kaku, T Nakano, H
Citation: T. Kamura et al., Predicting pelvic lymph node metastasis in endometrial carcinoma, GYNECOL ONC, 72(3), 1999, pp. 387-391
Endometrial carcinoma associated with hyperplasia - Immunohistochemical study of angiogenesis and p53 expression
Authors: Kaku, T Kamura, T Hirakawa, T Sakai, K Amada, S Kobayashi, H Nakano, H
Citation: T. Kaku et al., Endometrial carcinoma associated with hyperplasia - Immunohistochemical study of angiogenesis and p53 expression, GYNECOL ONC, 72(1), 1999, pp. 51-55
Risultati: 1-25 | 26-38